|
Variable | | | |
|
RFS total—with PM covariates | | | 1542.1 |
Treatment group | 6.10 | 0.003 | |
Occasion | 2.58 | 0.02 | |
Less than 8 prior admissions | 6.73 | 0.01 | |
PANSS PM negative score | 23.34 | <0.0001 | |
PANSS PM positive score | 23.42 | <0.0001 | |
|
RFS total—with VDG covariates | | | 1538.8 |
Treatment group | 6.40 | 0.002 | |
Occasion | 2.32 | 0.03 | |
Less than 8 prior admissions | 5.91 | 0.02 | |
PANSS VDG negative score | 6.72 | 0.01 | |
PANSS VDG positive score | 44.14 | <0.0001 | |
|
RFS total—with PM covariates | | | 1484.0 |
Treatment group | 5.40 | 0.006 | |
Occasion | 5.91 | <0.0001 | |
Less than 8 prior admissions | 6.32 | 0.01 | |
Medication compliance | 5.31 | 0.02 | |
PANSS PM activation score | 8.75 | 0.003 | |
PANSS PM autistic preoccupation | 24.86 | <0.0001 | |
|
RFS total—with VDG covariates | | | 1520.1 |
Treatment group | 6.26 | 0.002 | |
Occasion | 4.01 | 0.0008 | |
Less than 8 prior admissions | 6.04 | 0.02 | |
PANSS VDG disorganized score | 36.78 | <0.0001 | |
PANSS VDG excited score | 5.41 | 0.02 | |
|
SAS-SMI total—with PM covariates | | | 2431.1 |
Female | 3.12 | 0.08 | |
PANSS PM negative score | 17.45 | <0.0001 | |
PANSS PM positive score | 14.50 | 0.0002 | |
|
SAS-SMI total—with VDG covariates | | | 2399.7 |
Female | 6.02 | 0.02 | |
No schizoaffective diagnosis | 4.84 | 0.03 | |
Less than 8 prior inpatient admissions | 4.46 | 0.04 | |
PANSS VDG negative score | 11.93 | 0.0006 | |
PANSS VDG positive score | 26.63 | <0.0001 | |
|
SAS-SMI total—with PM covariates | | | 2430.1 |
Treatment group x occasion | 1.89 | 0.04 | |
PANSS PM activation score | 7.05 | 0.008 | |
PANSS PM autistic preoccupation score | 7.07 | 0.008 | |
|
SAS-SMI total—with VDG covariates | | | 2416.1 |
Treatment group | 2.33 | 0.01 | |
PANSS VDG disorganized score | 5.21 | 0.02 | |
PANSS VDG excited score | 10.69 | 0.001 | |
|
CSQ total—with PM covariates | | | 1531.8 |
Less than 8 prior inpatient admissions | 8.92 | 0.004 | |
PANSS PM negative score | 12.18 | 0.0006 | |
|
CSQ total—with VDG covariates | | | 1523.4 |
Less than 8 prior inpatient admissions | 7.13 | 0.009 | |
PANSS VDG negative score | 4.31 | 0.04 | |
PANSS VDG positive score | 14.07 | 0.0002 | |
|
CSQ total—with PM covariates | | | 1475.1 |
Less than 8 Prior inpatient admissions | 8.35 | 0.005 | |
Medication compliance | 4.62 | 0.03 | |
PANSS PM activation score | 25.88 | <0.0001 | |
|
CSQ total—with VDG covariates | | | 1474.6 |
Less than 8 prior inpatient admissions | 8.72 | 0.004 | |
Medication compliance | 4.27 | 0.04 | |
PANSS VDG excited score | 27.76 | <0.0001 | |
|
Adherence—with PM covariates | | | 3425.8 |
Occasion | 5.22 | <0.0001 | |
Treatment group x occasion | 3.34 | 0.0004 | |
Less than 5 inpt days in 6 months prior to baseline | 5.66 | 0.02 | |
No anticholinergic use (Cogentin) | 4.59 | 0.03 | |
|
Adherence—with VDG covariates | | | 3425.8 |
Occasion | 5.22 | <0.0001 | |
Treatment group x occasion | 3.34 | 0.0004 | |
Less than 5 inpt days in 6 months prior to baseline | 5.66 | 0.02 | |
No anticholinergic use (cogentin) | 4.59 | 0.03 | |
|
Compliance—with PM covariates | | | 702.1 |
Occasion | 8.36 | <0.0001 | |
Treatment group x occasion | 2.42 | 0.0007 | |
No anticholinergic use (cogentin) | 7.53 | 0.006 | |
|
Compliance—with VDG covariates | | | 702.1 |
Occasion | 8.36 | <0.0001 | |
Treatment group x occasion | 2.42 | 0.0007 | |
No anticholinergic use (cogentin) | 7.53 | 0.006 | |
|